Mig (Ibuprofen)

Ibuprofen, the active ingredient in Mig, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as a tablet for oral use. It relieves mild to moderate pain, reduces fever, and eases inflammation associated with conditions such as arthritis.

GNH USA supplies Mig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes.

Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort. Fever: lowers elevated body temperature in acute febrile states. Arthritis and other inflammatory conditions: decreases joint swelling and discomfort in osteoarthritis and rheumatoid arthritis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort or heartburn - Nausea or vomiting - Dizziness or light‑headedness - Headache - Mild rash or itching - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome - Acute kidney injury or worsening of chronic renal disease - Liver enzyme elevation or hepatitis - Cardiovascular events such as myocardial infarction in high‑risk patients

Use ibuprofen with awareness of potential risks and necessary monitoring.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding before initiating therapy. Monitor renal function: avoid or adjust dose in patients with severe kidney impairment. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Use lowest effective dose: limit duration to the shortest period needed for symptom control. Caution with concomitant anticoagulants: increased risk of bleeding. Store at ambient temperature: keep in the original pack, protect from moisture.

Ibuprofen may alter the effects of other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk - Lithium: elevated serum concentrations - Methotrexate: reduced renal clearance leading to toxicity

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor renal function and blood pressure - SSRIs: possible additive bleeding risk - Corticosteroids: heightened risk of gastrointestinal ulceration